secwatch.observer — SEC 8-K summary
======================================

Issuer:     Omada Health, Inc. (OMDA)
CIK:        0001611115
Form:       8-K
Filed at:   2026-08-06T20:02:04+00:00
Accession:  0001628280-26-054266
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Omada Health Q2 revenue $88M (+43% YoY), net income $5M; CEO transition to Executive Chair in 2027
--------------------------------------------------------------------------------

- Revenue $88M, up 43% YoY; gross margin 73% (record), up from 66% in Q2 2025.
- Net income $5M vs net loss $5M in Q2 2025; adjusted EBITDA $11M vs loss $0.2M.
- CEO Sean Duffy to become Executive Chair; President Wei-Li Shao to become CEO effective Jan 1, 2027.
- Total members increased 45% YoY; trailing twelve-month revenue per member $284.
- Cash and equivalents $222M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1611115/000162828026054266/0001628280-26-054266-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1611115/000162828026054266/omda-20260806.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-054266

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer